Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT02335151
Eligibility Criteria:
Inclusion Criteria:
* Age 18 to 85
* ASA I-III ( American Society of Anesthesiologists)
* Resectable pancreatic adenocarcinoma
* Primary surgery
* No neoadjuvant therapy
* Written informed consent
Exclusion Criteria:
* Metastatic disease
* Other than primary surgery (recurrence, reconstruction)
* Pre-operative chemotherapy
* Chronic opioid use
* Known hypersensitivity or suspected allergy to propofol, soya or egg proteins
* Known hypersensitivity to volatile anaesthetics (malignant hyperthermia)
* Pregnancy
* Breast feeding
* Enrolment in any other clinical trial during the course of this trial, 30 days prior to its beginning or 30 days after its completion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02335151
Study Brief:
Protocol Section:
NCT02335151